Clinical trials
Terminated Prediabetic State trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 3 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 5 |
| 2020 | 3 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stanford University | 3 |
| Emory University | 2 |
| Beth Israel Deaconess Medical Center | 1 |
| Brigham and Women's Hospital | 1 |
| Columbia University | 1 |
| Gary L. Pierce | 1 |
| Indiana University | 1 |
| Memorial Hermann Health System | 1 |
| Neurovalens Ltd. | 1 |
| Pennington Biomedical Research Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prediabetic State | 22 |
| Obesity | 6 |
| Diabetes Mellitus | 3 |
| Glucose Intolerance | 3 |
| Diabetes Mellitus, Type 2 | 2 |
| Inflammation | 2 |
| Metabolic Syndrome | 2 |
| Weight Loss | 2 |
| Cystic Fibrosis | 1 |
| Hypercholesterolemia | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.